Back to News
Market Impact: 0.25

CrowdStrike Just Split Its Stock 4-for-1. Does a $193 Price Tag Make It a Buy?

Artificial IntelligenceCompany FundamentalsCorporate EarningsCompany Guidance & OutlookValuation & Stock Split
CrowdStrike Just Split Its Stock 4-for-1. Does a $193 Price Tag Make It a Buy?

CrowStrike’s 4-for-1 stock split cut the share price from about $772 to about $193, but the business value didn’t change. Under the hood, fiscal Q1 revenue rose 26% YoY to $1.39B (vs. 23% in the prior quarter), with net new annual recurring revenue of $255.8M (+32% YoY) and free cash flow up 34% of revenue to a record $468M. However, the stock still trades at >150x management’s adjusted fiscal 2027 earnings guidance, implying heavy expectations and leaving the piece urging valuation patience despite accelerating fundamentals.

Analysis

The split is mostly a flow event, not a valuation event. With fractional trading now standard, the main mechanical effect is a short-lived boost in retail attention and options activity; that can support the stock for days, but it does not solve the core issue that the name already discounts several years of strong execution. If the post-split tape stays bid, it will likely be because momentum funds keep paying for “best-in-class” quality, not because the share count changed.

The more important read-through is competitive positioning inside cybersecurity. If AI-related security spend is real, it should lift the whole platform-security complex, but the highest incremental upside may actually sit in names with lower starting multiples and similar product breadth, especially PANW and ZS. CRWD has to keep compounding at a premium pace just to maintain its multiple; any pause in ARR conversion or billings efficiency would hit it harder than peers because expectations are already stretched.

Contrarianly, the market may be underpricing how durable AI-driven security demand can be over 6-18 months. If net new recurring revenue keeps outgrowing the installed base and FCF margin stays elevated, the current multiple can persist longer than skeptics expect. The thesis breaks if growth slips back toward the low-20s, FCF margin compresses, or management stops raising forward estimates; that would likely cause multiple compression before any fundamental deterioration shows up in revenue.